Efficacy and Safety Study of Augmentation Therapy With Aralast (Human Alpha 1 - Proteinase Inhibitor)

This study has been completed.

Study NCT00396006 Information provided by Baxter Healthcare Corporation

First Received: November 3, 2006 Last Updated: January 7, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)